Qiagen N.V. QGEN

Updated: 7 Sep 2026

NYSE | Biotech | Molecular diagnostics and sample technologies

No signal published yet

We already track Qiagen N.V. and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Qiagen N.V. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Molecular diagnostics and sample technologies
We're already tracking Qiagen N.V. — here are the latest events we've registered

Recent News

  • On August 24, 2026, Qiagen announced the appointment of Jonathan M. Pratt as Chief Executive Officer effective September 1, 2026. In early August 2026, the company reported second-quarter net sales of $535 million and an adjusted EPS of $0.62, beating its outlook and reaffirming full-year targets. On August 27, 2026, Qiagen launched QIAsymphony Connect to automate clinical nucleic acid extraction workflows.

What Firelda Watch includes for Qiagen N.V.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Qiagen N.V. will be delivered in the same format.

Want to follow Qiagen N.V.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Qiagen N.V. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Qiagen N.V. QGEN
Qiagen N.V. — follow and we'll monitor it
Follow Qiagen N.V. free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.